ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 190 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $213,652 | -13.0% | 10,252 | 0.0% | 0.08% | -7.1% |
| Q2 2023 | $245,535 | -12.9% | 10,252 | -24.6% | 0.08% | -16.8% |
| Q3 2018 | $282,000 | +24.2% | 13,593 | -8.6% | 0.10% | +29.5% |
| Q2 2018 | $227,000 | -7.7% | 14,872 | +68.9% | 0.08% | -10.3% |
| Q2 2017 | $246,000 | -21.2% | 8,807 | -3.0% | 0.09% | -18.7% |
| Q1 2017 | $312,000 | +19.1% | 9,083 | 0.0% | 0.11% | +12.6% |
| Q4 2016 | $262,000 | -9.3% | 9,083 | 0.0% | 0.10% | -13.6% |
| Q3 2016 | $289,000 | +2.1% | 9,083 | +4.0% | 0.11% | -6.0% |
| Q2 2016 | $283,000 | +40.8% | 8,733 | +37.7% | 0.12% | +27.2% |
| Q4 2014 | $201,000 | – | 6,340 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |